Related Experiment Videos
Risk and Protective Factors Scale: reliability and validity in preadolescents
1Department of Psychiatry, McGill University, Montreal, QC.
Summary
The Risk and Protective Factors Scale (RPFS) reliably identifies children at risk for disruptive behaviour disorders (DBDs). This new scale shows strong validity and may aid early intervention efforts.
Area of Science:
- Child Psychology
- Psychometric Assessment
- Developmental Psychopathology
Background:
- Disruptive Behaviour Disorders (DBDs) pose significant challenges in preadolescence.
- Early identification of risk factors is crucial for timely intervention.
- Existing assessment tools may require further validation or novel approaches.
Purpose of the Study:
- To evaluate the reliability and validity of the novel Risk and Protective Factors Scale (RPFS).
- To determine the RPFS's potential for predicting disruptive behaviour disorders in preadolescents.
Main Methods:
- A controlled study involving 120 children aged 6-12 years, divided into DBD and control groups.
- Administration of the RPFS alongside the Revised Child Behaviour Profile (RCBP) for comparison.
- Statistical analyses including interrater reliability (Cohen kappa), test-retest reliability (Pearson correlation), internal consistency (Cronbach alpha), and concurrent validity (Pearson correlation with RCBP).
Main Results:
- The RPFS demonstrated excellent interrater reliability (kappa=0.81) and test-retest reliability (r=0.76).
- High internal consistency (Cronbach alpha=0.89) and strong concurrent validity with the RCBP (r=0.82) were observed.
- The RPFS effectively discriminated between children with and without DBDs, indicating good discriminant validity.
Conclusions:
- The RPFS exhibits robust reliability and validity for assessing risk and protective factors in preadolescents.
- The scale shows promise in identifying children at risk for DBDs, potentially facilitating early intervention.
- Further longitudinal research is recommended to confirm the predictive power of the RPFS for DBD development.